Profound Aminos score history

Score over time

Every entry newest first

1. October 25, 2026Lowered from6.66→to6.65(-0.01)

   Pricing recomputed on 25 October 2026: listings added for a newly reviewed vendor (Pexo Labs) moved the market median for the same products: pricing 7.3 to 7.2.

2. October 24, 2026Raised from6.63→to6.66(+0.03)

   Prices and certificates re-read on 24 October 2026 in the owner's signed-in browser; other vendors move only through the market medians: pricing 7.1 to 7.3.

3. October 24, 2026Lowered from6.68→to6.63(-0.05)

   Pricing recomputed on 24 October 2026 after Bionova Peptides' first-review prices were recorded; other vendors move only through the market medians: pricing 7.4 to 7.1.

4. October 23, 2026Lowered from6.69→to6.68(-0.01)

   Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 7.5 to 7.4.

5. October 22, 2026Raised from6.68→to6.69(+0.01)

   Operating history re-checked on 22 October 2026 under the published rule (earliest dated evidence of the business, including a never-parked store domain and the named operating company, looked up for every vendor): operating history 3.1 to 3.4.

6. October 22, 2026Raised from6.51→to6.68(+0.17)

   Re-scored on 22 October 2026 under version 2 of our published rules. The deduction for verification codes the laboratory could not find was retired: each such certificate now keeps its points for the printed key and earns none for confirmation, and codes on certificates we do not score no longer count. Lab 7.6 to 7.9. Score 6.51 to 6.68.

7. October 22, 2026Lowered from6.66→to6.51(-0.15)

   Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 5.0 to 4.5, transparency 4.0 to 3.0.

8. October 22, 2026Lowered from6.77→to6.66(-0.11)

   Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. pricing 8.1 to 7.5, operating history 3.5 to 3.1.

9. October 22, 2026Lowered from6.83→to6.77(-0.06)

   Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for certificates more than 12 months old, site statements about testing that the certificates do not bear out, verification codes the issuing laboratory could not find and one lot number printed on certificates for different compounds. Lab 7.7 to 7.6.

10. October 22, 2026Raised from6.66→to6.83(+0.17)

    Lab evidence re-checked on 20 October 2026 under our coverage rule, which counts a listed product with no published certificate as zero in the lab average. Certificates cover 17 of the 17 products we list that the vendor offers for sale. Lab 7.4 to 7.7.

11. October 18, 2026Raised from6.39→to6.66(+0.27)

    Re-audited 2026-10-18 from the live site, replacing the May 2026 seed score. Lab 6.54 to 7.4: the certificate library is public, current and drawn from several laboratories, and we confirmed 152 certificates at Freedom Diagnostics, TrustPointe, Chromate and Zyntro; it is held back by the absence of endotoxin testing, nine Freedom reports not found at the laboratory, cap-colour rather than batch traceability and three products resting on 2025 reports. Shipping 7.9 to 5.0: no returns, refunds only against an outside lab result, a ten-day wait on lost parcels and peer-to-peer payment without buyer protection. Pricing 5.9 to 8.1: the full catalogue is now publicly priced and runs about 16% below the market median. Tenure 3.3 to 3.5 for a domain a little over two years old. Transparency 3.3 to 4.0: a mailing address, phone line and public certificate library, against no legal entity, no named people and coded GLP-1 names.